Cargando…

Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study

OBJECTIVE: To estimate the causal effect of increased use of neoadjuvant chemotherapy (NACT) on all cause mortality in advanced epithelial ovarian cancer. DESIGN: Quasi-experimental fuzzy regression discontinuity design and cross sectional analysis. SETTING: Cancer programs throughout the United Sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melamed, Alexander, Fink, Günther, Wright, Alexi A, Keating, Nancy L, Gockley, Allison A, del Carmen, Marcela G, Schorge, John O, Rauh-Hain, J Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751831/ https://www.ncbi.nlm.nih.gov/pubmed/29298771 http://dx.doi.org/10.1136/bmj.j5463

Ejemplares similares

Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation model
por: Lietz, Anna P., et al.
Publicado: (2019)

Total Pelvic Exenteration for Gynecologic Malignancies
por: Diver, Elisabeth J., et al.
Publicado: (2012)

Cancer‐directed surgery in patients with metastatic cancer: A systematic review and meta‐analysis of randomized evidence
por: Abel, Mary Kathryn, et al.
Publicado: (2023)

Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
por: Huang, Allan B., et al.
Publicado: (2021)

Do all patients with breast cancer benefit from neoadjuvant chemotherapy?
por: Lee, Kyoung Eun
Publicado: (2020)

Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer
por: Tobias, Claire J., et al.
Publicado: (2020)

Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study
por: Wright, Alexi A, et al.
Publicado: (2014)

Lived experience of women diagnosed with a gynecologic cancer in the height of the COVID-19 pandemic in New York City (508)
por: Yoh, Katherine, et al.
Publicado: (2022)

Intraoperative imaging identifies thymoma margins following neoadjuvant chemotherapy
por: Keating, Jane J., et al.
Publicado: (2015)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
por: Patel, Ami, et al.
Publicado: (2021)

Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
por: Cham, Stephanie, et al.
Publicado: (2022)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
por: Yu, Hong, et al.
Publicado: (2023)

Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma
por: Hegazy, Mohamed AF, et al.
Publicado: (2005)

Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
por: Chauhan, Sonali, et al.
Publicado: (2022)

Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer
por: Liu, Min, et al.
Publicado: (2022)

Neoadjuvant chemotherapy in advanced-stage ovarian cancer – state of the art
por: Margioula-Siarkou, Chrysoula, et al.
Publicado: (2022)

Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014
por: Wright, Jason D., et al.
Publicado: (2021)

Breast Cancer Subtype Specific Classifiers of Response to Neoadjuvant Chemotherapy Do Not Outperform Classifiers Trained on All Subtypes
por: de Ronde, Jorma J., et al.
Publicado: (2014)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011)

Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
por: McFerrin, Coleman, et al.
Publicado: (2020)

Using the precaution adoption process model and the health belief model to understand radon testing and mitigation: a pre-post quasi-experimental study
por: Maier, Allison, et al.
Publicado: (2023)

Telehealth Adoption and Discontinuation by US Hospitals: Results From 2 Quasi-Natural Experiments
por: Baird, Aaron, et al.
Publicado: (2022)

The Effects of Adopting Mobile Health and Fitness Apps on Hospital Visits: Quasi-Experimental Study
por: Bo, Yan, et al.
Publicado: (2023)

Impact of newly constructed primary healthcare centres on antenatal care attendance, facility delivery and all-cause mortality: quasi-experimental evidence from Taabo health and demographic surveillance system, Côte d’Ivoire
por: Koné, Siaka, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy in Invasive Bladder Cancer
por: Oliver, R.T.D.
Publicado: (1991)

Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas
por: Matsuo, Koji, et al.
Publicado: (2023)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

The role of neoadjuvant chemotherapy in ovarian cancer patients with extensive tumor burden
por: Kang, Sokbom
Publicado: (2011)

Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
por: Khandakar, Binny, et al.
Publicado: (2014)

Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
por: Baruah, Upasana, et al.
Publicado: (2015)

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
por: Mizuno, Takaaki, et al.
Publicado: (2020)

The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients
por: Mou, Daying, et al.
Publicado: (2022)

Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy?
por: Arianayagam, Ranjan, et al.
Publicado: (2018)

Laparoscopic diverting loop ileostomy for spontaneous colon perforation in advanced ovarian cancer
por: Schorge, John O.
Publicado: (2019)

Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
por: Cheng, Daoan, et al.
Publicado: (2023)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017)

Retroperitoneal Hematoma as an Atypical Presentation of Choriocarcinoma: A Case Report
por: Pham, Truce, et al.
Publicado: (2023)

Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab
por: Keating, Nancy L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uec7cegu23ogcdheabjei7n2l5